Hematopoiesis from human embryonic stem cells: overcoming the immune barrier in stem cell therapies.
The multipotency and proliferative capacity of human embryonic stem cells (hESCs) make them a promising source of stem cells for transplant therapies and of vital importance given the shortage in organ donation. Recent studies suggest some immune privilege associated with hESC-derived tissues. Howev...
Autores principales: | Priddle, H, Jones, DR, Burridge, P, Patient, R |
---|---|
Formato: | Journal article |
Lenguaje: | English |
Publicado: |
2006
|
Ejemplares similares
-
Embryonic stem cells: overcoming the immunological barriers to cell replacement therapy.
por: Lui, K, et al.
Publicado: (2009) -
Human embryonic stem cells /
por: Chiu, Arlene Y., et al.
Publicado: (2003) -
Human embryonic stem cell protocols /
por: Turksen, Kursad
Publicado: (2006) -
Programming haematopoietic stem cells in the embryonic dorsal aorta
por: Ciau-Uitz, A, et al.
Publicado: (2007) -
The embryonic origins and genetic programming of emerging haematopoietic stem cells
por: Ciau-Uitz, A, et al.
Publicado: (2016)